Sengenics

📍 Billerica, United States🗓 Founded 2008👥 63 employees💰 Last funded Oct 2020
Biotechnology🌐 sengenics.com
Website LinkedIn
Sengenics is a functional proteomics company that leverages its patented KREX protein folding technology to discover autoantibody biomarker signature for drug response prediction, patient stratification and development of companion diagnostics. Our technology ensure that all microarray proteins are full length, correctly folded and functional, enabling specific and quantitative antibody binding to conformational epitopes. The company has a global footprint with multiple corporate and research sites across the world with customers and collaborators that include top pharma, biotech and ivy league academic institutions in North America, Europe, and Asia.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Sweden
1
Singapore
1
Frequently asked questions
Who invested in Sengenics?
Sengenics has 2 investors on record on gritt.io.
When did Sengenics last raise funding?
The most recent investment in Sengenics recorded on gritt.io was in October 2020.
When was Sengenics founded?
Sengenics was founded in 2008.
What industry is Sengenics in?
Sengenics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Sengenics based?
Sengenics is headquartered in Billerica, United States.